The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 08, 2011
Filed:
Nov. 20, 2006
Bradley Teegarden, San Diego, CA (US);
Yifeng Xiong, San Diego, CA (US);
Sonja Strah-pleynet, San Diego, CA (US);
Honnappa Jayakumar, San Diego, CA (US);
Peter I. Dosa, San Diego, CA (US);
Konrad Feichtinger, San Diego, CA (US);
Martin Casper, San Diego, CA (US);
Juerg Lehmann, San Diego, CA (US);
Robert M. Jones, San Diego, CA (US);
David J. Unett, San Diego, CA (US);
Jin Sun Karoline Choi, San Diego, CA (US);
Bradley Teegarden, San Diego, CA (US);
Yifeng Xiong, San Diego, CA (US);
Sonja Strah-Pleynet, San Diego, CA (US);
Honnappa Jayakumar, San Diego, CA (US);
Peter I. Dosa, San Diego, CA (US);
Konrad Feichtinger, San Diego, CA (US);
Martin Casper, San Diego, CA (US);
Juerg Lehmann, San Diego, CA (US);
Robert M. Jones, San Diego, CA (US);
David J. Unett, San Diego, CA (US);
Jin Sun Karoline Choi, San Diego, CA (US);
Arena Pharmaceuticals, Inc., San Diego, CA (US);
Abstract
The present invention relates to certain 3-phenyl-pyrazole derivatives of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HTserotonin receptor and are useful, optionally in combination with other pharmaceutical agents administered separately or together, in the treatment of platelet aggregation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, reducing the risk of blood clot formation, asthma or symptoms thereof, agitation or a symptom, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorder, psychosis, acute schizophrenia, chronic schizophrenia, NOS schizophrenia and related disorders, and sleep disorders, sleep disorders, diabetic-related disorders, progressive multifocal leukoencephalopathy and the like.